These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4508920)

  • 1. Titration of the acceptor cross-linking sites in fibrin.
    Lorand L; Chenoweth D; Gray A
    Ann N Y Acad Sci; 1972 Dec; 202():155-71. PubMed ID: 4508920
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-linking of fibrin by fibrin=stabilizing factor.
    McKee PA; Schwartz ML; Pizzo SV; Hill RL
    Ann N Y Acad Sci; 1972 Dec; 202():127-48. PubMed ID: 4565368
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrin-stabilizing factor inhibitors.
    Nilsson JL; Stenberg P; Ljunggren C; Hoffman KJ; Lundén R; Eriksson O; Lorand L
    Ann N Y Acad Sci; 1972 Dec; 202():286-96. PubMed ID: 4508928
    [No Abstract]   [Full Text] [Related]  

  • 4. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
    Achyuthan KE; Dobson JV; Greenberg CS
    Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue transamidases, fibrin stabilization and clot lysis.
    Tyler HM
    Ann N Y Acad Sci; 1972 Dec; 202():273-85. PubMed ID: 4565369
    [No Abstract]   [Full Text] [Related]  

  • 6. - cross-linking sites in human and bovine fibrin.
    Chen R; Doolittle RF
    Biochemistry; 1971 Nov; 10(24):4487-91. PubMed ID: 5168975
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative studies on tissue transglutaminase and factor XIII.
    Chung SI
    Ann N Y Acad Sci; 1972 Dec; 202():240-55. PubMed ID: 4629552
    [No Abstract]   [Full Text] [Related]  

  • 8. Hereditary aspects of fibrin cross-linking.
    Hampton JW; Garrison D; Morton RO; Bannerjee D
    Ann N Y Acad Sci; 1972 Dec; 202():204-12. PubMed ID: 4629551
    [No Abstract]   [Full Text] [Related]  

  • 9. Polypeptide chains of human fibrin: molecular organization in cross-linking.
    McDonagh RP; McDonagh J; Blombäck B
    Ann N Y Acad Sci; 1972 Dec; 202():335-40. PubMed ID: 4508931
    [No Abstract]   [Full Text] [Related]  

  • 10. Enzymatic coupling of isoniazid to proteins.
    Lorand L; Campbell LK; Robertson BJ
    Biochemistry; 1972 Feb; 11(3):434-8. PubMed ID: 4110351
    [No Abstract]   [Full Text] [Related]  

  • 11. A filter paper assay for transamidating enzymes using radioactive amine substrates.
    Lorand L; Campbell-Wilkes LK; Cooperstein L
    Anal Biochem; 1972 Dec; 50(2):623-31. PubMed ID: 4674979
    [No Abstract]   [Full Text] [Related]  

  • 12. Transamidating enzymes. I. Rapid chromatographic assays.
    Lorand L; Campbell LK
    Anal Biochem; 1971 Nov; 44(1):207-20. PubMed ID: 5167290
    [No Abstract]   [Full Text] [Related]  

  • 13. Human fibrinogen free of factor XIII: the pursuit of biological zero.
    Finlayson JS
    Ann N Y Acad Sci; 1972 Dec; 202():149-54. PubMed ID: 4629549
    [No Abstract]   [Full Text] [Related]  

  • 14. Localization of the alpha-chain cross-link acceptor sites of human fibrin.
    Fretto LJ; Ferguson EW; Steinman HM; McKee PA
    J Biol Chem; 1978 Apr; 253(7):2184-95. PubMed ID: 632262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrin-stabilizing factor inhibitors. 11. Monodansylated weak aliphatic diamines.
    Ljunggren C; Hoffmann KJ; Stenberg P; Svensson U; Nilsson JL; Hartkoorn A; Lundén R
    J Med Chem; 1974 Jun; 17(6):649-51. PubMed ID: 4829944
    [No Abstract]   [Full Text] [Related]  

  • 16. Human Factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin.
    Schwartz ML; Pizzo SV; Hill RL; McKee PA
    J Biol Chem; 1973 Feb; 248(4):1395-407. PubMed ID: 4405643
    [No Abstract]   [Full Text] [Related]  

  • 17. Human fibrinogen heterogeneities. I. Structural and related studies of plasma fibrinogens which are high solubility catabolic intermediates.
    Mosesson MW; Finlayson JS; Umfleet RA; Galanakis D
    J Biol Chem; 1972 Aug; 247(16):5210-9. PubMed ID: 4262568
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrinoligase: the fibrin-stabilizing factor system of blood plasma.
    Lorand L
    Ann N Y Acad Sci; 1972 Dec; 202():6-30. PubMed ID: 4565370
    [No Abstract]   [Full Text] [Related]  

  • 19. A thiocholine ester of cinnamic acid inhibits crosslinking of fibrin without specific binding to donor lysines.
    Perret BA; Seelich T; Furlan M; Beck EA
    Thromb Haemost; 1979 Jun; 41(4):695-701. PubMed ID: 483243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epsilon-(gamma-glutamyl) lysine cross-links: determination in fibrin from normal and factor XIII-deficient individuals.
    Pisano JJ; Bronzert TJ; Peyton MP; Finlayson JS
    Ann N Y Acad Sci; 1972 Dec; 202():98-113. PubMed ID: 4629559
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.